PPD Phase 1 Clinic - Orlando is a clinical research site located in Orlando, Florida, United States 32806.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
PPD Phase 1 Clinic - Orlando has participated in 1 clinical trials.
Therapeutic areas: Ornithine Transcarbamylase Deficiency.
Sponsors: Ultragenyx Pharmaceutical Inc.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
PPD Phase 1 Clinic - Orlando has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
PPD Phase 1 Clinic - Orlando has 1 clinical trials on record. Their work covers Ornithine Transcarbamylase Deficiency.
PPD Phase 1 Clinic - Orlando has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.